“Repeal” and “replace” are the new buzzwords, with no signs of being bumped from the headlines anytime soon. Since the 2016 election, the Affordable Care Act (ACA) has been in the crosshairs of the Republican-controlled Congress and Donald Trump. The … Continue reading
It’s that time of year again. Time for vibrant fall colors, cool crisp morning air, and open enrollment in the Affordable Care Act (ACA) insurance exchanges—the government-regulated, state-based healthcare plans set up as part of the act. Since the ACA’s … Continue reading
For those who may be unfamiliar with the players in the pharmaceutical business, Mylan is a successful, mid-sized manufacturer of branded and generic drugs. One of their largest products is the EpiPen, which is an auto-injection device used to treat … Continue reading
